Jinghong Wang

Jinghong Wang

Auto-generated profile, based on publicly available information

Jinghong Wang

Department of Neurology, Houston Methodist Neurological Institute, Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX, United States

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 December 2018 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
EKElizabeth A. Killion
Elizabeth A. Killion
JWJinghong Wang
Jinghong Wang
JYJunming Yie
Junming Yie
SSStone D.-H. Shi
Stone D.-H. Shi
DBDarren Bates
Darren Bates
DLDavid J. Lloyd
David J. Lloyd
Antibody antagonists of the insulinotropic receptor GIPR prevent weight gain in obese animal models, and the effect is enhanced by GLP-1R agonists.

22 June 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
ATAaron D. Thome
Aaron D. Thome
JTJason R. Thonhoff
Jason R. Thonhoff
WZWeihua Zhao
Weihua Zhao
AFAlireza Faridar
Alireza Faridar
JWJinghong Wang
Jinghong Wang
SAStanley H. Appel
Stanley H. Appel
Extracellular vehicles (EVs) are efficient biomarkers of disease and participate in disease pathogenesis; however, their use as clinical therapies to modify disease outcomes remains to be determined. Cell-based immune therapies, including regulatory T cells (Tregs), are currently being clinically evaluated for their usefulness in suppressing pro-inflammatory processes. The present study demonstrates that ex vivo expanded Tregs generate a large pool of EVs that express Treg-associated markers and suppress pro-inflammatory responses in vitro and in vivo. Intravenous injection of Treg EVs into an LPS-induced mouse model of inflammation reduced peripheral pro-inflammatory transcripts and increased anti-inflammatory transcripts in myeloid cells as well as Tregs. Intranasal administration of enriched Treg EVs in this model also reduced pro-inflammatory transcripts and the associated neuroinflammatory responses. In a mouse model of amyotrophic lateral sclerosis, intranasal administration of enriched Treg EVs slowed disease progression, increased survival, and modulated inflammation within the diseased spinal cord. These findings support the therapeutic potential of expanded Treg EVs to suppress pro-inflammatory responses in human disease.

5 April 2016 in Neurology
Verified
Journal Article
Closed access
WZWeihua Zhao
Weihua Zhao
DBDavid Beers
David Beers
JTJason Thonhoff
Jason Thonhoff
DNDan Neal
Dan Neal
SWShixiang Wen
Shixiang Wen
SAStanley H. Appel
Stanley H. Appel